Fluticasone and vilanterol typically come as a dry powder inhaler (e.g., Ellipta device) and are usually inhaled once daily, at around the same time each day. It is crucial to follow the specific instructions provided with your inhaler device and by your healthcare professional. Do not use this medication to relieve a sudden asthma or COPD attack; a separate rescue inhaler should be used for acute symptoms. After each use, rinse your mouth with water and spit it out without swallowing to help prevent oral fungal infections (thrush). Do not open the inhaler cover until you are ready for a dose, as it could lead to a lost dose. Consistency in daily use is vital for long-term control of your condition.

• Use once daily, around the same time.
• Administer using a dry powder inhaler device.
• Not for acute attacks; use a rescue inhaler for sudden symptoms.
• Rinse mouth with water and spit after each use to prevent thrush.

Fluticasone and vilanterol work synergistically to improve breathing in respiratory conditions. Fluticasone is a corticosteroid that reduces inflammation in the airways. It does this by preventing various cells in the lungs from releasing substances that cause inflammation, swelling, and mucus production, which are key contributors to asthma and COPD symptoms. Vilanterol is a long-acting beta2-adrenergic agonist (LABA). It works by stimulating beta2 receptors on the smooth muscles around the airways, causing these muscles to relax and the airways to open up. This bronchodilation effect makes it easier for air to flow in and out of the lungs. The combination provides both anti-inflammatory action and long-lasting bronchodilation, addressing two major aspects of these chronic lung diseases.

• Fluticasone (corticosteroid) reduces airway inflammation.
• Vilanterol (LABA) relaxes airway muscles, opening them up.
• Fluticasone prevents release of inflammatory substances.
• Vilanterol stimulates beta2 receptors for bronchodilation.

Like all medications, fluticasone and vilanterol can cause side effects. Common side effects include headache, sore throat, cough, hoarseness, and oral thrush (fungal infection in the mouth/throat), which can often be prevented by rinsing your mouth after use. More serious, though less common, side effects can include pneumonia (especially in COPD patients), increased risk of infections due to a weakened immune system, adrenal suppression, eye problems like glaucoma or cataracts, and bone thinning (osteoporosis). Rarely, paradoxical bronchospasm (sudden worsening of breathing after inhalation) can occur. Report any severe or persistent side effects, or any signs of infection or vision changes, to your doctor immediately.

• Common: headache, sore throat, cough, hoarseness, oral thrush.
• Serious (less common): pneumonia, increased infections, adrenal suppression.
• Risk of eye problems (glaucoma, cataracts) and bone thinning.
• Paradoxical bronchospasm is a rare but serious immediate effect.

Before using fluticasone and vilanterol, inform your doctor about all your medical conditions, especially heart problems (e.g., high blood pressure, irregular heartbeat), thyroid problems, diabetes, glaucoma, cataracts, seizures, or a history of infections (e.g., tuberculosis). This medication is not a rescue inhaler and should not be used for sudden breathing problems. Do not exceed the prescribed dose, as this can increase the risk of side effects. Long-term use of corticosteroids can lead to systemic effects, including adrenal suppression, so avoid abrupt discontinuation, especially if you have been on high doses of oral corticosteroids. Regular eye exams and bone density checks may be recommended during prolonged treatment.

• Not for acute relief; use a rescue inhaler for sudden symptoms.
• Inform doctor about heart conditions, thyroid issues, diabetes, glaucoma, etc.
• Do not exceed prescribed dose; avoid abrupt discontinuation.
• Regular eye exams and bone density checks may be necessary.

Fluticasone and vilanterol can interact with other medications, requiring careful consideration. Due to the fluticasone component, interactions can occur with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir), which can increase the systemic exposure to fluticasone and vilanterol, potentially leading to increased side effects, including corticosteroid-related effects. The vilanterol component, a LABA, should not be used with other LABAs, as this can increase the risk of cardiovascular side effects. Beta-blockers, even eye drops, can reduce the effectiveness of vilanterol. Always inform your doctor or pharmacist about all prescription drugs, over-the-counter medications, herbal supplements, and dietary supplements you are currently taking to avoid potentially serious interactions.

• Interacts with strong CYP3A4 inhibitors (e.g., ketoconazole).
• Do not use with other long-acting beta-agonists (LABAs).
• Beta-blockers can reduce vilanterol’s effectiveness.
• Inform healthcare providers about all medications and supplements.

The dosage of fluticasone and vilanterol is prescribed as a single inhalation once daily. The specific strength (e.g., 100/25 mcg or 200/25 mcg, where fluticasone is the first number and vilanterol the second) will be determined by your doctor based on your condition (asthma or COPD), its severity, and your previous response to treatments. For asthma, the starting dose depends on prior inhaled corticosteroid use. For COPD, typically only one specific strength is indicated. Always take your dose at the same time each day and do not use more than one inhalation within a 24-hour period. Never adjust your dosage or stop treatment without consulting your healthcare provider.

• One inhalation once daily.
• Strength (e.g., 100/25 mcg) determined by doctor based on condition severity.
• Take at the same time each day.
• Do not exceed one inhalation per 24 hours.

Fluticasone and vilanterol combination inhalers are prescription-only medications. This means you must obtain a valid prescription from a licensed healthcare professional, such as a pulmonologist or a general practitioner, to acquire this medicine. The prescription ensures that your doctor has assessed your specific respiratory condition, determined the appropriate dosage, and reviewed your medical history for any contraindications or potential drug interactions. Due to the nature of both corticosteroid and long-acting bronchodilator components, medical supervision is essential to manage potential side effects and monitor the effectiveness of the treatment for optimal lung health.

• Requires a valid prescription from a licensed healthcare professional.
• Not available over-the-counter.
• Ensures appropriate use based on medical assessment.
• Medical supervision is essential for managing side effects and monitoring effectiveness.

1. What is Fluticasone and Vilanterol used for? To control symptoms of asthma and COPD, including wheezing, shortness of breath, and chest tightness.

2. What drug class does it belong to? Combination of inhaled corticosteroid (ICS) and long-acting beta agonist (LABA).

3. Is it a controlled substance? No, it is not classified as a controlled substance.

4. Is it available in generic form? Not currently; only branded as Breo Ellipta.

5. What forms and strengths are available? Dry powder inhaler:

• 100 mcg fluticasone / 25 mcg vilanterol

• 200 mcg fluticasone / 25 mcg vilanterol

6. How is it administered? One inhalation once daily using the Ellipta device.

7. What age group is it approved for? Adults with COPD; adults and children ≥18 years for asthma.

8. What are common side effects? Headache, throat irritation, cough, hoarseness, and upper respiratory infections.

9. Can it cause serious reactions? Yes—pneumonia, glaucoma, osteoporosis, adrenal suppression, and paradoxical bronchospasm.

10. Is it safe during pregnancy? Use only if clearly needed; consult a healthcare provider.

11. Can it be used with rescue inhalers? Yes, but it does not replace fast-acting bronchodilators.

12. How long does it take to work? Improvement may be seen within days; full effect in several weeks.

13. Is a prescription required? Yes, it is prescription-only.

14. Is it available in Pakistan? Yes, under brand name Breo Ellipta or imported equivalents.

15. Can it be used long-term? Yes, for maintenance therapy in asthma and COPD.

16. What makes it different from other inhalers? Once-daily dosing and combination of ICS + LABA in a single device.

17. Is it used for acute asthma attacks? No, it is not a rescue medication.

18. Can it be used with other asthma medications? Yes, often alongside leukotriene inhibitors or rescue inhalers.

19. What monitoring is needed? Lung function tests, eye exams, bone density, and adrenal function.

20. What should be avoided during use? Smoking, abrupt discontinuation, and sharing inhalers.